Barely Significant
← all excerpts

Assessment of the Effect of Erenumab on Efficacy and Quality-of-Life Parameters in a Cohort of Migraine Patients With Treatment Failure in Cyprus.

Front Neurol · 2021 · PMC8358110 · PMID 34393974

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

highly significantp < 0.001actually significant
As shown from the mean and median values, all migraine parameters improved following erenumab treatment, and the change was highly significant for almost all migraine parameters ( p < 0.001 for parameters 1, 5, and 8; p = 0.001 for parameters 2 and 4; and p = 0.003 for parameter 6).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.